Impact of High Dietary Fiber on Microbiome and Vaccine Responses
NCT05565586 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31
Last updated 2026-03-04
Summary
To learn if diet can enhance the microbes (such as bacteria and viruses) found in your gut and improve the body's immune response to the influenza (flu) vaccine.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
High-Fiber Diet (HFD)
Participants are assigned to the high fiber diet, all meals and snacks will be provided to participants during the study. This diet includes fruits, vegetables and whole grains, a maximum of 18 oz. cooked red meat (including beef, pork, and lamb) per week, and little or no processed meats or added sugars.
- DIETARY_SUPPLEMENT
-
Prebiotic Food-Enriched Diet (PreFED)
Participants are assigned to the prebiotic food enriched diet, participants will receive 2 prepared snacks and 1 meal component (a key prebiotic ingredient to incorporate into meals and simple recipes) each day. Participants will also receive a handout that includes key prebiotic foods to incorporate into your own diet.
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Jennifer Wargo, MD · M.D. Anderson Cancer Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-08-23
- Primary Completion
- 2029-01-02
- Completion
- 2029-01-02
Countries
- United States
Study Locations
More Related Trials
-
Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults
NCT01258842 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of the Safety and Effectiveness of a Probiotic Bacterium to Boost the Immune Response to Influenza Vaccines
NCT00294788 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Immune Response Study of Influenza Vaccine
NCT01310374 ·Status: COMPLETED
-
Cholecalciferol and Flu Vaccine in Treating Healthy Participants
NCT01561989 ·Status: TERMINATED ·Phase: NA
-
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
NCT04579588 ·Status: RECRUITING
-
Impact of Metabolic Syndrome on Flu Vaccine Efficacy
NCT02653495 ·Status: TERMINATED ·Phase: NA
-
Impact of FLU Vaccination on Nasal Resident Memory Immune Responses and Peripheral Respiratory-tropic Memory Immune Responses
NCT06824779 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Vaccine Efficacy in Diabetic and Elderly Patients
NCT02675608 ·Status: COMPLETED
-
Fasting-mimicking Diet and Immunosenescence
NCT02554188 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Effect of Influenza Vaccination on the Systemic Inflammatory Response and Myocardial Protection in Patients Undergoing Cardiac Surgery: a Randomized Controlled Trial
NCT02565277 ·Status: COMPLETED ·Phase: PHASE4
-
Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults
NCT03743688 ·Status: COMPLETED
-
Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases
NCT05078905 ·Status: RECRUITING
-
Precision Vaccine Promotion in Underserved Populations
NCT05537441 ·Status: COMPLETED ·Phase: NA
-
Persistence of Immune Response After Vaccination With Influenza Vaccine
NCT01906190 ·Status: COMPLETED ·Phase: NA
-
Systems Biological Assessment of Statin Effect on Vaccine Responses
NCT06024096 ·Status: COMPLETED ·Phase: PHASE4
-
Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination
NCT04794829 ·Status: RECRUITING
-
Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults
NCT05875961 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Blueberries on Immunity
NCT05534893 ·Status: COMPLETED ·Phase: NA
-
Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant
NCT02680002 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of Freeze-dried Live Attenuated Influenza Vaccine for Intranasal Administration in Chinese Adults Aged 3 Years and Older
NCT02665871 ·Status: UNKNOWN ·Phase: PHASE1
-
Open-Label Influenza Vaccine Evaluation
NCT02872311 ·Status: COMPLETED ·Phase: NA
-
DNA-based Influenza Vaccine in the Elderly
NCT01587131 ·Status: COMPLETED ·Phase: PHASE1
-
The Interaction Between Mucosal Microbiota Colonization and the Immune Response to an Intranasal Influenza Live Attenuated Vaccine
NCT06609811 ·Status: COMPLETED ·Phase: PHASE4
-
The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine
NCT05056519 ·Status: UNKNOWN ·Phase: PHASE1
-
The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine
NCT05284851 ·Status: UNKNOWN ·Phase: PHASE2